Patient Access Insights

Health Economics for Non-Health Economists

In this webinar, our Health Economics team provide an introduction to this topic, to early Health Economic models and explain the advantages of modelling.
Request this webinar
Patient%20Access%20Insights%20Banner%20Image

Health Economics for Non-Health Economists

Originally Broadcast: Tuesday, 5th May 2020

Duration: 60 minutes. Available to watch on demand

Learning objectives:

  •  Consider why we need economic evaluations

  •  Explain what a QALY is

  •  Describe how to derive utility

  •  Recognise the advantages of modelling

  •  Understand the importance of developing early health economic models

  •  Identify types of early health economic models

  •  Understand types of analyses in early health economic models

  •  Discuss lessons learnt from HTA bodies’ critique of models using case studies

  • The Pharma and MedTech job functions that will benefit most include:

  •  Heads of Market Access

  •  Country Managers

  •  Commercial Directors

  •  Marketing Directors

  •  Managing Directors

  •  Chief Executives

  •  Medical Directors

  •  Policy Officers and Executives

  •  Policy Advisors

Christian%201x
Christian Hill

Chief Executive Officer


Peter

Peter Rouse

Senior Consultant
Health Economics and Outcomes Research

Nermina

Nermina Ferizović

Consultant
Health Economics and Outcomes Research and Real-world Evidence

If you are unable to join the live Webinar, please still register and we will forward the slide decks afterwards.

Terms and ConditionsPrivacy PolicyCookie Policy

Copyright © 2020. MAP BioPharma Limited. All rights reserved.

MAP BioPharma Limited
Upper Pendrill Court, Ermine Street North
Papworth Everard, Cambridge
Cambridgeshire, CB23 3UY
United Kingdom

+44 (0) 1480 832360

 enquiries@mapbiopharma.com

MAP BioPharma Limited is a registered company in England and Wales. Company Registration Number 08209281

VAT Group Registration Number GB 292 8576 52